NovaBay Pharmaceuticals, Inc. EPS Growth (basic)

EPS Growth (basic) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS Growth (basic) growth rates and interactive chart. Year over year growth in basic earnings per share.


Highlights and Quick Summary

  • EPS Growth (basic) for the quarter ending June 30, 2022 was 0.0% (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly EPS Growth (basic) decreased by -100.0%
  • Annual EPS Growth (basic) for 2021 was 51.61% (a 45.71% increase from previous year)
  • Annual EPS Growth (basic) for 2020 was 35.42% (a -914.25% decrease from previous year)
  • Annual EPS Growth (basic) for 2019 was -4.35% (a -204.32% decrease from previous year)
  • Twelve month EPS Growth (basic) ending June 30, 2022 was 45.0% (a -30.25% decrease compared to previous quarter)
  • Twelve month trailing EPS Growth (basic) decreased by -24.4% year-over-year
Trailing EPS Growth (basic) for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
45.0% 64.52% 54.55% 59.52%
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS Growth (basic) of NovaBay Pharmaceuticals, Inc.

Most recent EPS Growth (basic)of NBY including historical data for past 10 years.

Interactive Chart of EPS Growth (basic) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. EPS Growth (basic) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0% 100.0%
2021 50.0% 37.5% 73.33% 33.33% 51.61%
2020 69.23% -700.0% -7.14% 78.57% 35.42%
2019 -85.71% 88.89% -55.56% -115.38% -4.35%
2018 -240.0% 43.75% 18.18% 50.0% 4.17%
2017 145.45% 52.94% 69.44% 79.03% 65.71%
2016 91.27% 80.57% 79.43% 44.89% 79.47%
2015 44.0% 12.5% -16.67% -12.5% 12.0%
2014 -190.0% 20.0% 45.45% 27.27% 26.19%
2013 225.0% 0.0% -37.5% -22.22% -75.0%
2012 42.86% 0.0% -500.0% -12.5% -20.0%
2011 -1500.0% 100.0% -11.11%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology